Search Results from ClinicalConnection

28 studies found

This is an 18 month study for subjects with mild/early alzheimer's disease.

The purpose of this study is to determine if the study medication given, in addition to your current medication Aricept(Donezepil), Razadyne (Galantamine) or Rivastigmine (Exelon) can improve memory,...

Randomized, double-blind, placebo-controlled, parallel-group, 18-month safety and Efficacy study of Leuco-methylthioninium bis(hydromethanesulfonate) in subjects with mild Alzheimer’s disease. ...

Mild to moderate Alzheimer's disease or memory loss.

The TOMMORROW study seeks to learn more about the genetic risk for developing mild cognitive impairment due to Alzheimer’s disease (MCI due to AD) and whether an investigational medication might prov...

Are you beginning to experience a decline in your memory and thinking skills?

California Neuroscience Research is conducting a research study on dementia caused by early Alzheim...

The study is for individuals with Alzheimer's Disease or mild cognitive impairment due to Alzheimer's Disease. The study lasts 18 months with an optional 24 month long-term extension. The study inc...

<123>